Login / Signup

Specific immunotherapy in local allergic rhinitis: A randomized, double-blind placebo-controlled trial with Phleum pratense subcutaneous allergen immunotherapy.

Carmen RondónNatalia Blanca-LópezP CampoCristobalina MayorgaR Jurado-EscobarM J TorresG CantoM Blanca
Published in: Allergy (2017)
Subcutaneous immunotherapy with depigmented polymerized allergen extracts is a safe and clinically effective treatment for LAR to P. pratense.
Keyphrases
  • allergic rhinitis
  • double blind
  • placebo controlled
  • study protocol
  • randomized controlled trial
  • phase iii
  • open label